![]() Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer. | ![]() Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | ![]() Anavex Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases. | |
Founding Date | Founding Date 2013 | Founding Date 1994 | Founding Date 2006 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Zug, CH | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations New York, US HQ Reno, US |
Employees | Employees 1347% decrease | Employees 38927% decrease | Employees 1623% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 96.2 m | Valuation ($) 484.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $12.4m (FY, 2022) | Revenue (est.) $156.3m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $600k (FY, 2022) | Cost of goods $3.1m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $11.8m (FY, 2022) | Gross profit $153.2m (FY, 2023) | Gross profit N/A |
Net income | Net income ($740.9m) (FY, 2022) | Net income ($257.4m) (FY, 2023) | Net income ($43m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 171.1m | Total funding raised $ 12.6m |
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View companyAnavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.
View company